DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $741.5 million versus the consensus estimate of $720.67 million.

GUIDANCE:

DexCom sees FY2023 revenue of $3.4-3.515 million, versus the consensus of $3.47 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.